ROYCE & ASSOCIATES LP

Position in RGEN — Repligen Corp

CIK 906304 New York, NY

Position in RGEN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$23,848,893

+$10,189,785 QoQ

Shares Held

174,794

+50.8% QoQ

Ownership

0.310%

of shares outstanding

% of Portfolio

0.19%

of 13F equity value

Holder Rank

#66

of 476 holders

Holding Since

Mar 2022

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ROYCE & ASSOCIATES LP holds $221,060,137 across 12 Medical Instruments & Supplies names. RGEN ranks #4 (10.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AVTR	Avantor, Inc.	3,676,084	$36,393,231
2	NVST	Envista Holdings Corp	1,270,717	$33,483,392
3	ANGO	Angiodynamics Inc	1,969,835	$25,627,553
4	RGEN	Repligen Corp This page	174,794	$23,848,893
5	AZTA	Azenta, Inc.	891,419	$22,749,012
6	BLFS	Biolife Solutions Inc	623,875	$17,618,230
7	STVN	Stevanato Group S.p.A.	916,356	$16,558,552
8	COO	Cooper Companies, Inc.	223,879	$16,054,363

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$23,848,893	174,794	+50.8%	Shares	Sole	2026-08-14
2026-03-31	$13,659,108	115,932	-21.1%	Shares	Sole	2026-05-12
2025-12-31	$24,082,995	146,973	-1.1%	Shares	Sole	2026-02-09
2025-09-30	$19,871,114	148,658	+66.1%	Shares	Sole	2025-11-12
2025-06-30	$11,134,746	89,522	+733.6%	Shares	Sole	2025-08-11
2023-03-31	$1,808,018	10,739	-88.4%	Shares	Sole	2023-05-23
2022-12-31	$15,650,847	92,439	-7.6%	Shares	Sole	2023-05-23
2022-09-30	$18,728,588	100,094	-21.3%	Shares	Sole	2022-11-03
2022-06-30	$20,660,365	127,219	+41.0%	Shares	Sole	2022-08-04
2022-03-31	$16,965,718	90,200	—	Shares	Sole	2022-05-05
No filing history on record for this holder in this stock.